Table 2:
Model | Vitamin D at baseline | N | N delirium | Person-years | HR (95% CIs) | p-value |
---|---|---|---|---|---|---|
Model 1* | Sufficient (>50 nmol/L) | 162,514 | 1,484 | 1,728,790 | ||
Insufficient (25–50 nmol/L) | 145,890 | 1,521 | 1,530,801 | 1.38 (1.28 to 1.49) | 3.9*10–18 | |
Deficient (<25 nmol/L) | 42,916 | 629 | 440,778 | 2.49 (2.24 to 2.76) | 3.4*10–68 | |
+ adj. for education + smoking status~ | 160,120 | 1,439 | 1,703,633 | |||
Insufficient (25–50 nmol/L) | 143,609 | 1,472 | 1,507,279 | 1.37 (1.27 to 1.48) | 1.3*10–16 | |
Deficient (<25 nmol/L) | 42,012 | 618 | 431,646 | 2.38 (2.14 to 2.64) | 1.5*10–59 | |
+ excl. vitamin D supplements | 140,274 | 1,246 | 1,491,439 | |||
Insufficient (25–50 nmol/L) | 134,247 | 1,374 | 1,408,789 | 1.40 (1.29 to 1.52) | 6.2*10–17 | |
Deficient (<25 nmol/L) | 40,692 | 598 | 418,019 | 2.46 (2.21 to 2.74) | 2.1*10–59 | |
+ excl. co-morbidities^ | 121,070 | 448 | 1,290,397 | |||
Insufficient (25–50 nmol/L) | 115,022 | 473 | 1,209,590 | 1.32 (1.15 to 1.51) | 4.1*10–5 | |
Deficient (<25 nmol/L) | 33,924 | 211 | 349,874 | 2.40 (2.00 to 2.89) | 6.0*10–21 | |
+ adj. for calcium~ | 110,391 | 406 | 1,176,061 | |||
Insufficient (25–50 nmol/L) | 105,366 | 447 | 1,107,064 | 1.37 (1.19 to 1.58) | 8.9*10–6 | |
Deficient (<25 nmol/L) | 31,194 | 197 | 321,497 | 2.45 (2.02 to 2.97) | 2.6*10–20 | |
+ adj. Frailty Index~ | 92,593 | 327 | 987,394 | |||
Insufficient (25–50 nmol/L) | 86,341 | 348 | 907,548 | 1.31 (1.12 to 1.54) | 6.1*10–4 | |
Deficient (<25 nmol/L) | 24,556 | 153 | 253,166 | 2.33 (1.88 to 2.89) | 1.3*10–14 |
Excl.=excluding diagnoses of. Adj.=models adjusted for. N=sample size included in the model. N delirium=the number of incident delirium cases included in the model. HR=Hazard Ratio. CIs=Confidence Intervals.
Cox’s proportional hazards regression models adjusted for age, sex, assessment centre, assessment month, and self-reported ethnicity.
at baseline assessment, participants with missing data excluded.
Ever diagnosed with bone fracture, CKD, dementia, liver disease, or Parkinson’s disease in the hospital admissions data to March 2020, prevalent or incident.